Neuro-Oncology Reviews
Volume
26 Number 14
20 July 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 14, 20 July
Nafe R, Hattingen E.
Forms of
Non-Apoptotic Cell Death and Their Role in Gliomas-Presentation of
the Current State of Knowledge.
Biomedicines.
2024 Jul 11;12(7):1546. doi:
10.3390/biomedicines12071546. PMID:
39062119. Review. ˍ
Pichardo-Rojas PS, Pichardo-Rojas D,
Marín-Castañeda LA, Palacios-Cruz M, Rivas-Torres
YI, Calderón-Magdaleno LF, Sánchez-Serrano CD,
Chandra A, Dono A, Karschnia P, Tonn JC, Esquenazi Y.
Prognostic
value of surgical resection over biopsy in elderly patients with
glioblastoma: a meta-analysis.
J
Neurooncol. 2024 Jul 11. doi:
10.1007/s11060-024-04752-w. PMID:
38990444. Meta-analysis˰
ˍ
Del
Baldo G, Carai A, Mastronuzzi A.
Chimeric
antigen receptor adoptive immunotherapy in central nervous system
tumors: state of the art on clinical trials, challenges, and
emerging strategies to addressing them.
Curr
Opin Oncol.
2024 Jul 12. doi:
10.1097/CCO.0000000000001076. PMID:
38989708. Review. ˍ
Jezierzański M, Nafalska N, Stopyra M, Furgoł T, Miciak
M, Kabut J, Gisterek-Grocholska I.
Temozolomide
(TMZ) in the Treatment of Glioblastoma Multiforme-A Literature
Review and Clinical Outcomes.
Curr
Oncol. 2024 Jul 12;31(7):3994-4002. doi:
10.3390/curroncol31070296. PMID:
39057168. Review. ˍ
Bou-Gharios J, Noël G, Burckel H.
Preclinical
and clinical advances to overcome hypoxia in glioblastoma
multiforme.
Cell
Death Dis. 2024 Jul 13;15(7):503. doi:
10.1038/s41419-024-06904-2. PMID:
39003252.
Review. ˍ
Habibi MA, Ghorbani M, Esmaeilian S, Tajvidi F, Nekutalaban P,
Boskabadi AR, Alemi F, Zafari R, Mirjani MS, Eazi S, Minaee P.
Stereotactic radiosurgery versus
combined stereotactic radiosurgery and bevacizumab for recurrent
glioblastoma; a systematic review and meta-analysis of survival.
Neurosurg
Rev. 2024 Jul 13;47(1):323. doi:
10.1007/s10143-024-02585-9. PMID:
39002028. Review; Meta-analysis˰
ˍ
Dondi F, Miceli A, Rovera G, Feudo V, Battisti C, Rondini M,
Marongiu A, Mura A, Camedda R, De Feo MS, Conte M, Gorica J,
Ferrari C, Nappi AG, Santo G.
Prostate-Specific
Membrane Antigen Radioligand Therapy in Non-Prostate Cancers:
Where Do We Stand?
Bioengineering
(Basel). 2024 Jul 14;11(7):714. doi:
10.3390/bioengineering11070714. PMID:
39061796. Review. ˍ
Sanikommu S, Panchawagh S, Eatz T, Lu VM, Rodrigues PB, Abdelsalam
A, Gurses ME, Cummings A, Uppalapati V, Akurati S, Kondoor V,
Komotar RJ, Ivan ME.
Recurrence of
atypical and anaplastic intracranial Meningiomas: A meta-analysis
of risk factors.
Clin
Neurol Neurosurg. 2024 Jul 14;244:108450. doi:
10.1016/j.clineuro.2024.108450. PMID:
39018991. Meta-analysis˰
ˍ
Park JE, Park YW, Kim YH, Song SW, Hong CK, Kim JH, Kim HS.
Determining Progressive Disease Using
RANO 2.0-Further Clarifications and Explanations.
Korean
J Radiol. 2024 Jul 15. doi:
10.3348/kjr.2024.0476. PMID:
39028016. Comment. ˍ
Related
Article
*won se, suh ch, kim s, park hj, kim kw.
Summary
of Key Points of the Response Assessment in Neuro-Oncology (RANO)
2.0.
Korean
J Radiol.
2024 Apr 11. doi:
10.3348/kjr.2024.0016. PMID:
38627876. Editorial. ˍ
Schiff D.
Low-Grade Gliomas: A New
Mutation, New Targeted Therapy, and Many Questions.
Neurology.
2024 Jul 15;103(3):e209688. doi: 10.1212/WNL.0000000000209688.
PMID: 39008801. Review˰
ˍ
Zhao B, Yao L, Hatami M, Ma W, Skutella T.
Vaccine-based
immunotherapy and related preclinical models for glioma.
Trends
Mol Med. 2024 Jul 15:S1471-4914(24)00167-9. doi:
10.1016/j.molmed.2024.06.009. PMID:
39013724. Review. ˍ
Ali TE, Rodoshi ZN, Salcedo YE, Patel VK, Khan I.
Optimizing
Glioma Resection Outcomes: A Systematic Review of Intraoperative
Magnetic Resonance Imaging Guidance in Neurosurgery.
Cureus.
2024 Jul 16;16(7):e64697. doi:
10.7759/cureus.64697. PMID:
39156414. Review. ˍ
Chai X, Zhang Y, Zhang W, Feng K, Jiang Y, Zhu A, Chen X, Di L,
Wang R.
Tumor Metabolism: A New Field
for the Treatment of Glioma.
Bioconjug
Chem. 2024 Jul 16. doi:
10.1021/acs.bioconjchem.4c00287. PMID:
39013195. Review˰ ˍ
Erker C, Vanan MI, Larouche V, Nobre L, Cacciotti C, Vairy S,
Zelcer S, Fleming A, Bouffet E, Jabado N, Legault G, Renzi S,
McKeown T, Crooks B, Thacker N, Ramaswamy V, Coltin H,
Lafay-Cousin L, Cheng S, Hukin J, Climans SA, Lim-Fat MJ, McKillop
S, Lapointe S, Alves M, Bennett J, Tabori U, Perreault S.
Canadian
Consensus for Treatment of BRAF V600E
Mutated Pediatric and AYA Gliomas.
Curr
Oncol. 2024 Jul 16;31(7):4022-4029. doi:
10.3390/curroncol31070299. PMID:
39057171. Guidelines. ˍ
Chung C, Buczkowicz P.
Editorial:
Recent advances in the molecular genetics of glioma.
Front
Genet. 2024 Jul 17;15:1435186. doi:
10.3389/fgene.2024.1435186. PMID:
39086473. Editorial. ˍ
Ius T, Somma T, Pasqualetti F, Berardinelli J, Vitulli F, Caccese
M, Cella E, Cenciarelli C, Pozzoli G, Sconocchia G, Zeppieri M,
Gerardo C, Caffo M, Lombardi G.
Local
therapy in glioma: An evolving paradigm from history to horizons
(Review).
Oncol
Lett. 2024 Jul 17;28(3):440. doi:
10.3892/ol.2024.14573. PMID:
39081966. Review. ˍ
Iqbal J, Hafeez MH, Amin A, Moradi I, Chhabra A, Iqbal A, Patel T,
Shafique MA, Nadeem A, Jamil U.
Synergistic
effects of herpes oncolytic virus and cyclophosphamide for
recurrent malignant glioma: a narrative review.
Ann
Med Surg (Lond). 2024 Jul 17;86(9):5354-5360. doi:
10.1097/MS9.0000000000002384. PMID:
39239066. Review. ˍ
Patel T, Singh G, Goswami P.
Recent
updates in pediatric diffuse glioma classification: insights and
conclusions from the WHO 5th
edition.
J
Med Life. 2024 Jul;17(7):665-670. doi:
10.25122/jml-2023-0515. PMID:
39440342. Review. ˍ
Power
EA, Millesi E, Rechberger JS, Daniels DJ.
CAR-T
cells for H3K27-altered diffuse midline gliomas: where do we
stand?
Immunotherapy.
2024 Jul 17:1-4. doi:
10.1080/1750743X.2024.2373043. PMID:
39016046. Editorial˰ ˍ
Caglar YS, Buyuktepe M, Sayaci EY, Dogan I, Bozkurt M, Peker E,
Soydal C, Ozkan E, Kucuk NO.
Hybrid
Positron Emission Tomography and Magnetic Resonance Imaging Guided
Microsurgical Management of Glial Tumors: Case Series and Review
of the Literature.
Diagnostics
(Basel). 2024 Jul 18;14(14):1551. doi:
10.3390/diagnostics14141551. PMID:
39061688. Case report; Review. ˍ
Senger
S, Radtke K, Oertel J.
Full
Endoscopic Transcranial Resection of Meningiomas.
Adv
Tech Stand Neurosurg.
2024 Jul 18;52:129-138. doi:
10.1007/978-3-031-61925-0_10. PMID:
39017791. Review; Book chapter˰ ˍ
Bao J, Sun R, Pan Z, Wei S.
Current
chemotherapy strategies for adults with IDH-wildtype glioblastoma.
Front
Oncol. 2024 Jul 19;14:1438905. doi:
10.3389/fonc.2024.1438905. PMID:
39099691. Review. ˍ
Gorodezki D, Schuhmann MU, Ebinger M, Schittenhelm J.
Dissecting
the Natural Patterns of Progression and Senescence in Pediatric
Low-Grade Glioma: From Cellular Mechanisms to Clinical
Implications.
Cells.
2024 Jul 19;13(14):1215. doi:
10.3390/cells13141215. PMID:
39056798. Review. ˍ
Lin MD, Tsai AC, Abdullah KG, McBrayer SK, Shi DD.
Treatment
of IDH-mutant glioma in the INDIGO era.
NPJ
Precis Oncol. 2024 Jul 19;8(1):149. doi:
10.1038/s41698-024-00646-2. PMID:
39025958. Review. ˍ
Chakrabarti I, Mazumder S.
What
Changed in CNS5? A Mini-Review on General Changes and Adult
Diffuse Gliomas.
Ann
Afr Med. 2024 Jul 20;23(3):255-261. doi:
10.4103/aam.aam_63_23. PMID:
39034544. Review. ˍ
Kamel R, Van den Berge D.
Radiotherapy
for subependymal giant cell astrocytoma: time to challenge a
historical ban? A case report and review of the literature.
J
Med Case Rep. 2024 Jul 20;18(1):330. doi:
10.1186/s13256-024-04649-2. PMID:
39030575. Case report; Review. ˍ